Phibro Animal Health Corporation Stock Price, News & Analysis (NASDAQ:PAHC)

$34.65 -0.50 (-1.42 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$35.15
Today's Range$34.35 - $35.20
52-Week Range$26.10 - $40.25
Volume42,867 shs
Average Volume115,389 shs
Market Capitalization$1.41 billion
P/E Ratio22.97
Dividend Yield1.12%
Beta1.35

About Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health Corporation logoPhibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Veterinary Drugs
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Debt-to-Equity Ratio1.91%
Current Ratio3.26%
Quick Ratio1.85%

Price-To-Earnings

Trailing P/E Ratio22.97
Forward P/E Ratio22.07
P/E Growth4.12

Sales & Book Value

Annual Sales$764.30 million
Price / Sales1.82
Cash Flow$2.16 per share
Price / Cash16.02
Book Value$4.22 per share
Price / Book8.21

Profitability

Trailing EPS$1.70
Net Income$64.61 million
Net Margins8.87%
Return on Equity42.75%
Return on Assets9.84%

Miscellaneous

Employees1,400
Outstanding Shares40,180,000

Frequently Asked Questions for Phibro Animal Health Corporation (NASDAQ:PAHC)

What is Phibro Animal Health Corporation's stock symbol?

Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?

Phibro Animal Health Corporation declared a quarterly dividend on Tuesday, November 7th. Stockholders of record on Wednesday, December 6th will be given a dividend of $0.10 per share on Wednesday, December 27th. This represents a $0.40 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Tuesday, December 5th. View Phibro Animal Health Corporation's Dividend History.

How were Phibro Animal Health Corporation's earnings last quarter?

Phibro Animal Health Corporation (NASDAQ:PAHC) released its earnings results on Monday, November, 6th. The company reported $0.38 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.37 by $0.01. The company earned $193.40 million during the quarter, compared to the consensus estimate of $189.89 million. Phibro Animal Health Corporation had a return on equity of 42.75% and a net margin of 8.87%. Phibro Animal Health Corporation's revenue was up 2.9% on a year-over-year basis. During the same period last year, the firm earned $0.36 earnings per share. View Phibro Animal Health Corporation's Earnings History.

When will Phibro Animal Health Corporation make its next earnings announcement?

Phibro Animal Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, February, 5th 2018. View Earnings Estimates for Phibro Animal Health Corporation.

What guidance has Phibro Animal Health Corporation issued on next quarter's earnings?

Phibro Animal Health Corporation updated its FY18 earnings guidance on Monday, November, 6th. The company provided earnings per share (EPS) guidance of $1.55-1.61 for the period, compared to the Thomson Reuters consensus estimate of $1.56. The company issued revenue guidance of $765-790 million, compared to the consensus revenue estimate of $780.13 million.

Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?

3 equities research analysts have issued 12 month target prices for Phibro Animal Health Corporation's shares. Their predictions range from $33.00 to $42.00. On average, they expect Phibro Animal Health Corporation's stock price to reach $37.33 in the next year. View Analyst Ratings for Phibro Animal Health Corporation.

What are Wall Street analysts saying about Phibro Animal Health Corporation stock?

Here are some recent quotes from research analysts about Phibro Animal Health Corporation stock:

  • 1. According to Zacks Investment Research, "Phibro ended  second-quarter fiscal 2017 on a mixed note, with bottom line exceeding the Zacks Consensus Estimate and revenues declining marginally on a year-over-year basis. Segment-wise, a persistent decline in Mineral Nutrition segment sales is likely to prove a drag. Customer consolidation can also adversely affect Phibro’s revenues. Moreover, headwinds such as unfavorable currency movement and tough competitive scenario continue to pose threats. Over the past three months, Phibro has been trading below the broader industry. However, on a positive note, Animal Health remained the key contributing business, delivering positive growth on a year-over-year basis. We are also encouraged by the expansion in the gross margin in the reported quarter." (11/8/2017)
  • 2. Piper Jaffray Companies analysts commented, "We continue to favor shares of PAHC as a top small cap idea in our ag space, where we see potential for upward revisions to guidance in 2H17 following the 2Q earnings beat and management reaffirming guidance. Positively, the Animal Health segment grew in the December-ending quarter despite ongoing headwinds in MFAs, supporting our thesis around the resilience of the animal health industry. We are lifting our FY17 EPS estimate to $1.45 at the top of the guidance range and we see potential earnings upside in 2H17 from growth outside of MFAs and in other geographies like Brazil. We see multiple expansion opportunity with some of the MFA overhang on the stock removed after the resilient 2Q results and our price target moves to $34 based on 21X FY18E EPS of $1.60. We reiterate our Overweight rating." (2/8/2017)

Who are some of Phibro Animal Health Corporation's key competitors?

Who are Phibro Animal Health Corporation's key executives?

Phibro Animal Health Corporation's management team includes the folowing people:

  • Jack Clifford Bendheim, Chairman of the Board, President, Chief Executive Officer (Age 70)
  • Richard G. Johnson, Chief Financial Officer (Age 68)
  • Dean J. Warras, President - Animal Health & Nutrition, North America (Age 48)
  • Larry Lee Miller, Chief Operating Officer (Age 53)
  • Daniel M. Bendheim, Executive Vice President, Director, Corporate Strategy (Age 45)
  • Thomas Golden Dagger, Senior Vice President, General Counsel, Corporate Secretary (Age 59)
  • Lisa A. Escudero, Senior Vice President of Human Resources (Age 55)
  • David C. Storbeck, Vice President - Finance, Treasurer (Age 63)
  • Gerald K. Carlson, Director (Age 74)
  • E. Thomas Corcoran, Independent Director (Age 70)

Who owns Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (1.17%), Ameriprise Financial Inc. (1.08%), Thornburg Investment Management Inc. (1.00%), Bank of New York Mellon Corp (0.87%), Fuller & Thaler Asset Management Inc. (0.44%) and Eagle Asset Management Inc. (0.39%). Company insiders that own Phibro Animal Health Corporation stock include Bfi Co, Llc, Daniel A Welch, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Gerald K Carlson, Jack Bendheim, Larry Lee Miller, Richard G Johnson and Thomas G Dagger. View Institutional Ownership Trends for Phibro Animal Health Corporation.

Who sold Phibro Animal Health Corporation stock? Who is selling Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., JPMorgan Chase & Co., Janus Henderson Group PLC, Wells Fargo & Company MN, Bank of New York Mellon Corp, Schwab Charles Investment Management Inc., Seizert Capital Partners LLC and Chicago Equity Partners LLC. Company insiders that have sold Phibro Animal Health Corporation company stock in the last year include Bfi Co, Llc, Daniel A Welch, Daniel M Bendheim, Dean J Warras, Gerald K Carlson, Jack Bendheim, Larry Lee Miller, Richard G Johnson and Thomas G Dagger. View Insider Buying and Selling for Phibro Animal Health Corporation.

Who bought Phibro Animal Health Corporation stock? Who is buying Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was bought by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Ameriprise Financial Inc., Prudential Financial Inc., Fuller & Thaler Asset Management Inc., Dimensional Fund Advisors LP, First Quadrant L P CA, OxFORD Asset Management LLP and U S Global Investors Inc.. View Insider Buying and Selling for Phibro Animal Health Corporation.

How do I buy Phibro Animal Health Corporation stock?

Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Phibro Animal Health Corporation's stock price today?

One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $34.65.

How big of a company is Phibro Animal Health Corporation?

Phibro Animal Health Corporation has a market capitalization of $1.41 billion and generates $764.30 million in revenue each year. The company earns $64.61 million in net income (profit) each year or $1.70 on an earnings per share basis. Phibro Animal Health Corporation employs 1,400 workers across the globe.

How can I contact Phibro Animal Health Corporation?

Phibro Animal Health Corporation's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health Corporation (PAHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  147 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  285
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Phibro Animal Health Corporation (NASDAQ:PAHC)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.092.222.112.13
Ratings Breakdown: 4 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.43$30.83$30.83$28.00
Price Target Upside: 6.28% downside17.56% downside18.32% downside3.78% downside

Consensus Price Target History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Price Target History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Analysts' Ratings History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/10/2017Piper Jaffray CompaniesReiterated RatingBuy$42.00N/AView Rating Details
8/31/2017Credit Suisse GroupBoost Price TargetOutperform$36.00 -> $37.00HighView Rating Details
8/23/2017Bank of America CorporationReiterated RatingUnderperform -> Underperform$33.00HighView Rating Details
11/11/2016MacquarieDowngradeNeutral -> Underperform$21.00N/AView Rating Details
11/10/2016GabelliDowngradeBuy -> HoldN/AView Rating Details
9/12/2016GuggenheimSet Price TargetBuy$26.00 -> $30.00N/AView Rating Details
9/4/2016Morgan StanleySet Price TargetSell$23.00N/AView Rating Details
1/15/2016Barclays PLCDowngradeOverweight -> Underweight$36.00 -> $31.00N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Phibro Animal Health Corporation (NASDAQ:PAHC)

Earnings by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Earnings History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018N/AView Earnings Details
11/6/2017Q1 2018$0.37$0.38$189.89 million$193.40 millionViewN/AView Earnings Details
8/30/2017Q4 2017$0.35$0.39$192.47 million$194.84 millionViewN/AView Earnings Details
5/8/2017Q3 2017$0.37$0.37$185.90 million$190.00 millionViewListenView Earnings Details
2/6/2017Q217$0.35$0.39$194.16 million$192.00 millionViewListenView Earnings Details
11/9/2016Q1 2017$0.34$0.36$188.85 million$188.00 millionViewListenView Earnings Details
8/29/2016Q416$0.38$0.40$189.20 millionViewN/AView Earnings Details
5/9/2016Q316$0.43$0.38$197.24 million$183.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.41$0.39$198.27 million$191.80 millionViewN/AView Earnings Details
11/9/2015Q1$0.41$0.44$192.28 million$187.10 millionViewN/AView Earnings Details
9/9/2015Q415$0.38$0.44$185.00 millionViewN/AView Earnings Details
5/11/2015Q315$0.36$0.41$187.80 million$187.50 millionViewN/AView Earnings Details
2/10/2015Q215$0.36$0.35$181.52 million$188.70 millionViewN/AView Earnings Details
11/11/2014Q115$0.35$0.51$174.90 million$187.50 millionViewN/AView Earnings Details
9/16/2014Q414$0.27$0.22$175.90 million$183.70 millionViewN/AView Earnings Details
5/13/2014Q314$0.14$0.21$162.70 million$173.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Phibro Animal Health Corporation (NASDAQ:PAHC)
Current Year EPS Consensus Estimate: $1.57 EPS
Next Year EPS Consensus Estimate: $1.68 EPS

Dividends

Current Dividend Information for Phibro Animal Health Corporation (NASDAQ:PAHC)

Next Dividend:12/27/2017
Annual Dividend:$0.40
Dividend Yield:1.15%
Payout Ratio:23.53% (Trailing 12 Months of Earnings)
25.48% (Based on This Year's Estimates)
23.81% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Dividend History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/7/2017quarterly$0.101.12%12/5/201712/6/201712/27/2017
7/25/2017quarterly$0.101.04%9/1/20179/6/20179/27/2017
5/9/2017Quarterly$0.101.2%5/26/20175/31/20176/22/2017
2/7/2017quarterly$0.101.37%2/27/20173/1/20173/22/2017
11/8/2016quarterly$0.101.51%11/28/201611/30/201612/21/2016
7/26/2016quarterly$0.101.95%9/2/20169/7/20169/28/2016
5/10/2016quarterly$0.102.17%5/27/20166/1/20166/22/2016
2/9/2016quarterly$0.101.18%2/29/20163/2/20163/23/2016
11/10/2015quarterly$0.101.26%11/30/201512/2/201512/23/2015
7/28/2015quarterly$0.101.08%8/31/20159/2/20159/23/2015
5/12/2015quarterly$0.101.09%6/1/20156/3/20156/24/2015
2/10/2015quarterly$0.101.43%3/2/20153/4/20153/25/2015
11/10/2014quarterly$0.101.43%12/1/201412/3/201412/23/2014
7/28/2014quarterly$0.108/29/20149/3/20149/24/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Phibro Animal Health Corporation (NASDAQ PAHC)

Insider Ownership Percentage: 51.88%
Institutional Ownership Percentage: 47.98%
Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)
Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017Dean J WarrasInsiderSell10,000$35.70$357,000.00View SEC Filing  
9/14/2017Larry Lee MillerCOOSell21,439$36.43$781,022.77View SEC Filing  
9/14/2017Richard G JohnsonCFOSell55,529$36.30$2,015,702.70View SEC Filing  
9/13/2017Larry Lee MillerCOOSell15,891$36.46$579,385.86View SEC Filing  
9/13/2017Richard G JohnsonCFOSell15,900$36.46$579,714.00View SEC Filing  
9/12/2017Larry Lee MillerCOOSell46,102$36.33$1,674,885.66View SEC Filing  
9/12/2017Richard G JohnsonCFOSell47,264$36.32$1,716,628.48View SEC Filing  
9/11/2017Gerald K CarlsonDirectorSell5,400$36.27$195,858.00View SEC Filing  
9/7/2017Larry Lee MillerCOOSell32,459$35.59$1,155,215.81View SEC Filing  
9/7/2017Richard G JohnsonCFOSell29,807$35.66$1,062,917.62View SEC Filing  
8/21/2017Daniel M BendheimVPSell4,976$40.01$199,089.76View SEC Filing  
8/16/2017Daniel M BendheimVPSell5,938$40.04$237,757.52View SEC Filing  
8/15/2017Daniel M BendheimVPSell1,443$40.05$57,792.15View SEC Filing  
8/14/2017Daniel M BendheimVPSell300$40.08$12,024.00View SEC Filing  
7/6/2017Bfi Co., LlcMajor ShareholderSell16,000$36.00$576,000.00View SEC Filing  
7/6/2017Jack BendheimInsiderSell32,000$36.49$1,167,680.00View SEC Filing  
7/5/2017Bfi Co., LlcMajor ShareholderSell16,000$36.98$591,680.00View SEC Filing  
6/30/2017Bfi Co., LlcMajor ShareholderSell48,000$37.42$1,796,160.00View SEC Filing  
6/23/2017Jack BendheimInsiderSell48,000$37.15$1,783,200.00View SEC Filing  
6/15/2017Bfi Co., LlcMajor ShareholderSell48,000$34.82$1,671,360.00View SEC Filing  
6/9/2017Jack BendheimInsiderSell48,000$35.62$1,709,760.00View SEC Filing  
5/25/2017Jack BendheimInsiderSell48,000$34.67$1,664,160.00View SEC Filing  
5/19/2017Jack BendheimInsiderSell48,000$34.15$1,639,200.00View SEC Filing  
5/11/2017Gerald K CarlsonDirectorSell63,338$33.31$2,109,788.78View SEC Filing  
5/10/2017Jack BendheimInsiderSell1,400$34.04$47,656.00View SEC Filing  
5/9/2017Larry Lee MillerCOOSell56,825$30.95$1,758,733.75View SEC Filing  
5/9/2017Thomas G DaggerSVPSell8,000$32.13$257,040.00View SEC Filing  
5/4/2017Larry Lee MillerCOOSell18,953$30.13$571,053.89View SEC Filing  
5/1/2017Larry Lee MillerCOOSell14,780$30.13$445,321.40View SEC Filing  
3/20/2017Gerald K CarlsonDirectorSell12,000$28.13$337,560.00View SEC Filing  
2/27/2017Gerald K CarlsonDirectorSell12,000$28.29$339,480.00View SEC Filing  
2/16/2017Daniel A WelchSVPSell5,000$29.55$147,750.00View SEC Filing  
2/16/2017Larry Lee MillerCOOSell4,588$30.00$137,640.00View SEC Filing  
2/15/2017Gerald K CarlsonDirectorSell12,000$29.77$357,240.00View SEC Filing  
2/13/2017Larry Lee MillerCOOSell97,229$30.37$2,952,844.73View SEC Filing  
1/4/2017Thomas G DaggerSVPSell207$30.00$6,210.00View SEC Filing  
1/3/2017Larry Lee MillerCOOSell187$30.00$5,610.00View SEC Filing  
12/20/2016Larry Lee MillerCOOSell1,540$30.04$46,261.60View SEC Filing  
12/20/2016Thomas G DaggerSVPSell1,700$30.03$51,051.00View SEC Filing  
12/19/2016Larry Lee MillerCOOSell252$30.00$7,560.00View SEC Filing  
12/19/2016Thomas G DaggerSVPSell200$30.01$6,002.00View SEC Filing  
5/19/2016E Thomas CorcoranDirectorBuy5,000$18.14$90,700.00View SEC Filing  
4/1/2016Gerald K CarlsonCOOSell8,000$27.02$216,160.00View SEC Filing  
2/19/2016Gerald K CarlsonCOOSell8,000$28.09$224,720.00View SEC Filing  
2/17/2016Bfi Co., LlcMajor ShareholderSell2,175$30.01$65,271.75View SEC Filing  
2/10/2016Bfi Co., Llcmajor shareholderSell3,400$30.78$104,652.00View SEC Filing  
2/3/2016Bfi Co., Llcmajor shareholderSell4,000$33.26$133,040.00View SEC Filing  
2/3/2016Jack BendheimCEOSell12,000$33.39$400,680.00View SEC Filing  
2/2/2016Bfi Co., Llcmajor shareholderSell4,000$33.44$133,760.00View SEC Filing  
2/1/2016Bfi Co., Llcmajor shareholderSell4,000$33.46$133,840.00View SEC Filing  
2/1/2016Larry Lee MillerPresidentSell60,000$33.58$2,014,800.00View SEC Filing  
1/29/2016Jack BendheimCEOSell39,944$32.10$1,282,202.40View SEC Filing  
1/26/2016Daniel A. WelchSVPSell3,000$32.05$96,150.00View SEC Filing  
1/26/2016Gerald K. CarlsonCOOSell12,923$32.13$415,215.99View SEC Filing  
1/22/2016Larry Lee MillerPresidentSell51,225$30.07$1,540,335.75View SEC Filing  
1/20/2016Gerald K. CarlsonCOOSell8,000$29.27$234,160.00View SEC Filing  
1/8/2016Larry Lee MillerPresidentSell4,303$30.03$129,219.09View SEC Filing  
1/6/2016Bfi Co., Llcmajor shareholderSell3,005$29.93$89,939.65View SEC Filing  
1/6/2016Jack BendheimCEOSell8,056$30.01$241,760.56View SEC Filing  
1/6/2016Larry Lee MillerPresidentSell4,472$30.10$134,607.20View SEC Filing  
1/5/2016Bfi Co., Llcmajor shareholderSell4,851$30.07$145,869.57View SEC Filing  
1/4/2016Bfi Co., Llcmajor shareholderSell200$29.92$5,984.00View SEC Filing  
12/30/2015Bfi Co., Llcmajor shareholderSell4,000$30.63$122,520.00View SEC Filing  
12/30/2015Jack BendheimCEOSell12,000$30.49$365,880.00View SEC Filing  
12/29/2015Bfi Co., Llcmajor shareholderSell4,000$30.49$121,960.00View SEC Filing  
12/28/2015Bfi Co., Llcmajor shareholderSell4,000$30.34$121,360.00View SEC Filing  
12/23/2015Gerald K. CarlsonCOOSell2,006$32.03$64,252.18View SEC Filing  
12/22/2015Gerald K. CarlsonCOOSell1,071$32.02$34,293.42View SEC Filing  
12/21/2015Gerald K. CarlsonCOOSell8,000$31.13$249,040.00View SEC Filing  
12/18/2015Jack BendheimCEOSell12,000$31.83$381,960.00View SEC Filing  
12/15/2015Larry Lee MillerinsiderSell36,090$31.00$1,118,790.00View SEC Filing  
12/14/2015Larry Lee MillerinsiderSell23,910$30.74$734,993.40View SEC Filing  
12/11/2015Jack BendheimCEOSell12,000$31.58$378,960.00View SEC Filing  
12/3/2015Jack BendheimCEOSell12,000$32.63$391,560.00View SEC Filing  
11/24/2015Gerald K. CarlsonCOOSell16,000$32.08$513,280.00View SEC Filing  
11/24/2015Thomas G. DaggerSVPSell4,000$32.87$131,480.00View SEC Filing  
11/18/2015Bfi Co., Llcmajor shareholderSell4,000$31.68$126,720.00View SEC Filing  
11/18/2015Jack BendheimCEOSell12,000$31.63$379,560.00View SEC Filing  
11/17/2015Bfi Co., Llcmajor shareholderSell4,000$31.71$126,840.00View SEC Filing  
11/16/2015Bfi Co., Llcmajor shareholderSell4,000$31.50$126,000.00View SEC Filing  
11/12/2015Bfi Co., Llcmajor shareholderSell12,000$32.21$386,520.00View SEC Filing  
11/5/2015Jack BendheimCEOSell12,000$33.11$397,320.00View SEC Filing  
10/30/2015Jack BendheimCEOSell12,000$33.21$398,520.00View SEC Filing  
10/26/2015Gerald K. CarlsonCOOSell7,900$32.15$253,985.00View SEC Filing  
10/26/2015Jack BendheimCEOSell12,000$31.73$380,760.00View SEC Filing  
10/21/2015Gerald K. CarlsonCOOSell8,100$32.40$262,440.00View SEC Filing  
10/16/2015Daniel A. WelchSVPSell3,000$32.93$98,790.00View SEC Filing  
10/16/2015Jack BendheimCEOSell12,000$32.10$385,200.00View SEC Filing  
10/9/2015Jack BendheimCEOSell12,000$30.64$367,680.00View SEC Filing  
10/1/2015Jack BendheimCEOSell12,000$31.44$377,280.00View SEC Filing  
9/25/2015Jack BendheimCEOSell10,000$33.95$339,500.00View SEC Filing  
9/23/2015Thomas G. DaggerSVPSell4,000$34.76$139,040.00View SEC Filing  
9/22/2015Gerald K. CarlsonCOOSell8,000$34.97$279,760.00View SEC Filing  
9/21/2015Gerald K. CarlsonCOOSell8,000$35.99$287,920.00View SEC Filing  
9/18/2015Jack BendheimCEOSell18,000$35.90$646,200.00View SEC Filing  
9/16/2015Dean J. WarrasinsiderSell4,000$34.73$138,920.00View SEC Filing  
9/10/2015Jack BendheimCEOSell18,000$34.69$624,420.00View SEC Filing  
9/3/2015Bfi Co., Llcmajor shareholderSell16,900$35.08$592,852.00View SEC Filing  
9/3/2015Jack BendheimCEOSell1,100$35.10$38,610.00View SEC Filing  
8/28/2015Jack BendheimCEOSell18,000$34.89$628,020.00View SEC Filing  
8/21/2015Gerald K. CarlsonCOOSell16,000$35.04$560,640.00View SEC Filing  
8/19/2015Bfi Co., LlcMajor ShareholderSell6,000$36.91$221,460.00View SEC Filing  
8/19/2015Jack BendheimCEOSell18,000$37.14$668,520.00View SEC Filing  
8/18/2015Bfi Co., LlcMajor ShareholderSell6,000$37.76$226,560.00View SEC Filing  
8/17/2015Bfi Co., LlcMajor ShareholderSell6,000$36.76$220,560.00View SEC Filing  
7/24/2015Jack BendheimCEOSell18,000$37.98$683,640.00View SEC Filing  
7/21/2015Gerald K CarlsonCOOSell8,000$37.97$303,760.00View SEC Filing  
7/20/2015Gerald K CarlsonCOOSell8,000$38.16$305,280.00View SEC Filing  
7/15/2015Bfi Co., LlcMajor ShareholderSell18,000$38.13$686,340.00View SEC Filing  
7/15/2015Jack BendheimCEOSell6,000$37.75$226,500.00View SEC Filing  
7/14/2015Jack BendheimCEOSell6,000$38.25$229,500.00View SEC Filing  
7/13/2015Jack BendheimCEOSell6,000$38.41$230,460.00View SEC Filing  
7/9/2015Jack BendheimCEOSell18,000$36.90$664,200.00View SEC Filing  
7/2/2015Bfi Co., LlcMajor ShareholderSell19,000$38.02$722,380.00View SEC Filing  
6/26/2015Jack BendheimCEOSell36,000$36.37$1,309,320.00View SEC Filing  
6/23/2015Gerald K CarlsonCOOSell16,000$36.56$584,960.00View SEC Filing  
6/22/2015Gerald K CarlsonCOOSell8,000$36.47$291,760.00View SEC Filing  
6/17/2015Bfi Co., LlcMajor ShareholderSell4,000$34.09$136,360.00View SEC Filing  
6/17/2015Jack BendheimCEOSell12,000$33.13$397,560.00View SEC Filing  
6/16/2015Bfi Co., LlcMajor ShareholderSell4,000$33.00$132,000.00View SEC Filing  
6/15/2015Bfi Co., LlcMajor ShareholderSell4,000$32.31$129,240.00View SEC Filing  
6/11/2015Jack BendheimCEOSell12,000$32.38$388,560.00View SEC Filing  
6/4/2015Jack BendheimCEOSell12,000$33.68$404,160.00View SEC Filing  
5/28/2015Bfi Co., LlcMajor ShareholderSell18,000$35.11$631,980.00View SEC Filing  
5/21/2015Gerald K CarlsonCOOSell16,000$35.62$569,920.00View SEC Filing  
5/19/2015Bfi Co., LlcMajor ShareholderSell18,000$36.73$661,140.00View SEC Filing  
5/18/2015Thomas G DaggerSVPSell4,000$36.48$145,920.00View SEC Filing  
12/19/2014Daniel A WelchSVPSell4,000$29.20$116,800.00View SEC Filing  
8/1/2014Bfi Co., LlcMajor ShareholderSell223,075$20.51$4,575,268.25View SEC Filing  
4/22/2014E Thomas CorcoranDirectorBuy5,000$16.70$83,500.00View SEC Filing  
4/16/2014Carol WrennDirectorBuy1,000$16.19$16,190.00View SEC Filing  
4/16/2014L.P. MayflowerMajor ShareholderSell6,323,867$13.99$88,470,899.33View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Phibro Animal Health Corporation (NASDAQ PAHC)

Source:
DateHeadline
Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 24, 2017Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 24, 2017
finance.yahoo.com - November 24 at 9:12 AM
Phibro Animal Health Corporation (PAHC) Expected to Post Earnings of $0.40 Per SharePhibro Animal Health Corporation (PAHC) Expected to Post Earnings of $0.40 Per Share
www.americanbankingnews.com - November 14 at 5:22 AM
Phibro Animal Health Corporation (PAHC) Receives Consensus Recommendation of "Hold" from AnalystsPhibro Animal Health Corporation (PAHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 13 at 2:34 AM
Phibro Animal Health Corporation 2018 Q1 - Results - Earnings Call SlidesPhibro Animal Health Corporation 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - November 12 at 11:25 AM
Piper Jaffray Companies Reiterates Buy Rating for Phibro Animal Health Corporation (PAHC)Piper Jaffray Companies Reiterates Buy Rating for Phibro Animal Health Corporation (PAHC)
www.americanbankingnews.com - November 11 at 9:42 AM
Phibro Animal Health Corporation (PAHC) Downgraded by ValuEngine to HoldPhibro Animal Health Corporation (PAHC) Downgraded by ValuEngine to Hold
www.americanbankingnews.com - November 9 at 10:30 PM
Edited Transcript of PAHC earnings conference call or presentation 7-Nov-17 2:00pm GMTEdited Transcript of PAHC earnings conference call or presentation 7-Nov-17 2:00pm GMT
finance.yahoo.com - November 9 at 11:01 AM
Phibro Animal Health Corporation (PAHC) Announces $0.10 Quarterly DividendPhibro Animal Health Corporation (PAHC) Announces $0.10 Quarterly Dividend
www.americanbankingnews.com - November 7 at 5:54 PM
Phibro Animal Health Corporation Reports First QuarterPhibro Animal Health Corporation Reports First Quarter
www.thestreet.com - November 7 at 8:26 AM
Phibro Animal (PAHC) Beats on Q1 Earnings, Reiterates ViewPhibro Animal (PAHC) Beats on Q1 Earnings, Reiterates View
www.zacks.com - November 7 at 8:26 AM
Phibro beats 1Q profit forecastsPhibro beats 1Q profit forecasts
finance.yahoo.com - November 7 at 8:26 AM
Phibro Animal Health Corporation Class A to Host Earnings CallPhibro Animal Health Corporation Class A to Host Earnings Call
finance.yahoo.com - November 7 at 8:26 AM
Phibro Animal Health Corporation (PAHC) Announces  Earnings ResultsPhibro Animal Health Corporation (PAHC) Announces Earnings Results
www.americanbankingnews.com - November 6 at 8:11 PM
Phibro Animal Health Corporation (PAHC) Releases FY18 Earnings GuidancePhibro Animal Health Corporation (PAHC) Releases FY18 Earnings Guidance
www.americanbankingnews.com - November 6 at 5:50 PM
Phibro Animal Health Corporation (PAHC) Rating Lowered to Hold at Zacks Investment ResearchPhibro Animal Health Corporation (PAHC) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - November 1 at 3:52 PM
Phibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : October 31, 2017Phibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : October 31, 2017
finance.yahoo.com - November 1 at 7:24 AM
Phibro Animal Health Corporation (PAHC) Rating Increased to Buy at Zacks Investment ResearchPhibro Animal Health Corporation (PAHC) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - October 31 at 3:25 PM
Phibro Animal Health Corporation (PAHC) Set to Announce Quarterly Earnings on MondayPhibro Animal Health Corporation (PAHC) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - October 30 at 10:44 AM
$0.38 Earnings Per Share Expected for Phibro Animal Health Corporation (PAHC) This Quarter$0.38 Earnings Per Share Expected for Phibro Animal Health Corporation (PAHC) This Quarter
www.americanbankingnews.com - October 24 at 4:18 PM
Phibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : October 20, 2017Phibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : October 20, 2017
finance.yahoo.com - October 21 at 8:00 AM
Phibro Animal Health Corporation (PAHC) Receives Consensus Rating of "Hold" from BrokeragesPhibro Animal Health Corporation (PAHC) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - October 19 at 2:34 AM
Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 17, 2017Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 17, 2017
finance.yahoo.com - October 17 at 8:51 PM
Phibro Animal Health Corporation to Participate in the Credit Suisse Healthcare ConferencePhibro Animal Health Corporation to Participate in the Credit Suisse Healthcare Conference
finance.yahoo.com - October 17 at 6:07 AM
Phibro Animal Health Corporation (PAHC) Given a $41.00 Price Target at Piper Jaffray CompaniesPhibro Animal Health Corporation (PAHC) Given a $41.00 Price Target at Piper Jaffray Companies
www.americanbankingnews.com - October 7 at 7:36 AM
Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 5, 2017Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 5, 2017
finance.yahoo.com - October 5 at 2:52 PM
Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2017 Quarterly Financial ResultsPhibro Animal Health Corporation to Host Webcast and Conference Call on September 2017 Quarterly Financial Results
feeds.benzinga.com - October 3 at 4:59 PM
Phibro Animal Health Corporation (PAHC) Receives Average Rating of "Hold" from AnalystsPhibro Animal Health Corporation (PAHC) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - September 24 at 12:42 AM
Earnings Review and Free Research Report: Phibro Animal Health’s Net Sales Grew 3%; Adjusted EPS Surged 22%Earnings Review and Free Research Report: Phibro Animal Health’s Net Sales Grew 3%; Adjusted EPS Surged 22%
finance.yahoo.com - September 22 at 8:08 AM
Phibro Animal Health Corporation (PAHC) Insider Sells $357,000.00 in StockPhibro Animal Health Corporation (PAHC) Insider Sells $357,000.00 in Stock
www.americanbankingnews.com - September 20 at 10:22 PM
Phibro Animal Health Corporation (PAHC) COO Sells $579,385.86 in StockPhibro Animal Health Corporation (PAHC) COO Sells $579,385.86 in Stock
www.americanbankingnews.com - September 15 at 10:46 PM
Phibro Animal Health Corporation (PAHC) COO Sells $781,022.77 in StockPhibro Animal Health Corporation (PAHC) COO Sells $781,022.77 in Stock
www.americanbankingnews.com - September 15 at 10:46 PM
Richard G. Johnson Sells 15,900 Shares of Phibro Animal Health Corporation (PAHC) StockRichard G. Johnson Sells 15,900 Shares of Phibro Animal Health Corporation (PAHC) Stock
www.americanbankingnews.com - September 15 at 10:46 PM
Insider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 55,529 Shares of StockInsider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 55,529 Shares of Stock
www.americanbankingnews.com - September 15 at 10:46 PM
Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q4, 2017 By the Numbers : September 12, 2017Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q4, 2017 By the Numbers : September 12, 2017
finance.yahoo.com - September 13 at 7:35 AM
Phibro Animal Health Corporation (PAHC) Director Sells $195,858.00 in StockPhibro Animal Health Corporation (PAHC) Director Sells $195,858.00 in Stock
www.americanbankingnews.com - September 12 at 10:16 PM
Phibro Animal Health Corporation (PAHC) COO Sells $1,674,885.66 in StockPhibro Animal Health Corporation (PAHC) COO Sells $1,674,885.66 in Stock
www.americanbankingnews.com - September 12 at 10:16 PM
Phibro Animal Health Corporation (PAHC) CFO Richard G. Johnson Sells 47,264 SharesPhibro Animal Health Corporation (PAHC) CFO Richard G. Johnson Sells 47,264 Shares
www.americanbankingnews.com - September 12 at 10:16 PM
Insider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 29,807 Shares of StockInsider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 29,807 Shares of Stock
www.americanbankingnews.com - September 8 at 1:22 PM
ETFs with exposure to Phibro Animal Health Corp. : September 7, 2017ETFs with exposure to Phibro Animal Health Corp. : September 7, 2017
finance.yahoo.com - September 8 at 6:56 AM
Insider Selling: Phibro Animal Health Corporation (PAHC) COO Sells 32,459 Shares of StockInsider Selling: Phibro Animal Health Corporation (PAHC) COO Sells 32,459 Shares of Stock
www.americanbankingnews.com - September 7 at 10:22 PM
Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: 2017 By the Numbers : September 6, 2017Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: 2017 By the Numbers : September 6, 2017
finance.yahoo.com - September 7 at 7:23 AM
Gabelli Comments on Phibro Animal Health Corporations FY2019 Earnings (PAHC)Gabelli Comments on Phibro Animal Health Corporation's FY2019 Earnings (PAHC)
www.americanbankingnews.com - September 4 at 8:32 AM
Phibro Animal Healths (PAHC) CEO Jack Bendheim on Q4 2017 Results - Earnings Call TranscriptPhibro Animal Health's (PAHC) CEO Jack Bendheim on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - September 2 at 7:19 AM
Phibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates OverweightPhibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates Overweight
www.streetinsider.com - September 2 at 7:19 AM
Piper Jaffray Companies Reiterates "Buy" Rating for Phibro Animal Health Corporation (PAHC)Piper Jaffray Companies Reiterates "Buy" Rating for Phibro Animal Health Corporation (PAHC)
www.americanbankingnews.com - September 1 at 2:16 PM
Edited Transcript of PAHC earnings conference call or presentation 31-Aug-17 1:00pm GMTEdited Transcript of PAHC earnings conference call or presentation 31-Aug-17 1:00pm GMT
finance.yahoo.com - September 1 at 6:57 AM
Credit Suisse Group Boosts Phibro Animal Health Corporation (PAHC) Price Target to $37.00Credit Suisse Group Boosts Phibro Animal Health Corporation (PAHC) Price Target to $37.00
www.americanbankingnews.com - August 31 at 5:02 PM
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal YearPhibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
finance.yahoo.com - August 31 at 8:27 AM
Phibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : August 30, 2017Phibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : August 30, 2017
finance.yahoo.com - August 31 at 8:27 AM
Phibro beats 4Q profit forecastsPhibro beats 4Q profit forecasts
finance.yahoo.com - August 31 at 8:27 AM

Social Media

Financials

Chart

Phibro Animal Health Corporation (NASDAQ PAHC) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.